Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study

Birgit Schramm, Elvis Temfack, Diane Descamps, +12

The Lancet HIV

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France

Diane Descamps, Marie‐Laure Chaix, Brigitte Montès, +20

Journal of Antimicrobial Chemotherapy

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011

Diane Descamps, Lambert Assoumou, Marie‐Laure Chaix, +25

Journal of Antimicrobial Chemotherapy

Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection

Benoît Visseaux, Quentin Le Hingrat, Gilles Collin, +8

Journal of Clinical Virology

Synthetic Aperture RadarRadar Image ProcessingRadar ApplicationCovid-19Radiology

Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses

Sidonie Lambert-Niclot, C. Charpentier, Alexandre Storto, +11

Journal of Antimicrobial Chemotherapy

Molecular Determinants of HIV-2 R5-X4 Tropism in the V3 Loop: Development of a New Genotypic Tool

Benoît Visseaux, Margarita Hurtado-Nédelec, C. Charpentier, +7

The Journal of Infectious Diseases

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

Charlotte Charpentier, Isabelle Malet, Elisabeth André‐Garnier, +22

Journal of Antimicrobial Chemotherapy

Hot Spots of Integrase Genotypic Changes Leading to HIV-2 Resistance to Raltegravir

Charlotte Charpentier, Bénédicte Roquebert, Olivier Delelis, +13

Antimicrobial Agents and Chemotherapy

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naive HIV-Infected Patients

Lucile Larrouy, Corine Chazallon, Roland Landman, +12

Antimicrobial Agents and Chemotherapy

<i>In Vitro</i>Phenotypic Susceptibility of HIV-2 Clinical Isolates to CCR5 Inhibitors

Benoît Visseaux, Charlotte Charpentier, Margarita Hurtado-Nédelec, +7

Antimicrobial Agents and Chemotherapy

R5 Hiv-1 IsolatesMaraviroc SusceptibilityHiv-2 SusceptibilityMedicineHuman Retrovirus +12